H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 6.63 +0.40 (6.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.23 | 52 Week High | $5.40 | |||
| Open | $6.24 | 52 Week Low | $1.88 | |||
| Day High | $6.93 | P/E | N/A | |||
| Day Low | $6.24 | EPS | $0.00 | |||
| Volume | 3,320,066 | |||||
